[1]
“Comparison of the GLP-1 Receptor Agonists with other anti-obesity/anti-diabetic medicines: a systematic review”, rjnmsr, vol. 3, no. 5, pp. 347–368, Sep. 2025, doi: 10.63075/w16p9p55.